Company news
Futura Medical plc news in 2026
Futura Medical plc's news releases, calls and decks from 2026, newest first.
Holding(s) in Company
November 11, 2026
Board Change and Formal Sale Process Update
October 8, 2026
Positive results from further Eroxon® Intense HUT
October 7, 2026
Holding(s) in Company
October 2, 2026
Holding(s) in Company
October 1, 2026
Correction: Result of GM and Total Voting Rights
September 24, 2026
Rule 2.9 Announcement
September 9, 2026
Oversubscribed Retail Offer
September 7, 2026
Disclosure Table
September 3, 2026
Unaudited Interim Results 2026
September 1, 2026
EU Market Launch Clearance
July 31, 2026
MED3000 (Eroxon®) European Patent Opposition
July 7, 2026
Highly positive data from WSD4000 studies
June 30, 2026
New US commercial partner
June 29, 2026
Notice of AGM & availability of Annual Report
June 4, 2026
Unaudited Results for the Year Ended 31 Dec 2025
April 29, 2026
Notice of Results & Investor Presentation
April 20, 2026
Positive Eroxon® & Eroxon® “Intense” HUT results
March 23, 2026
Formal Grant of US Patent
March 18, 2026
Holding(s) in Company
March 17, 2026
Patent notice of allowance granted for the US
February 5, 2026
Trading Update
February 4, 2026
Results of WSD4000 Early Feasibility Study
January 12, 2026
Notification of major holdings
January 7, 2026